• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

31.89 +0.15 (+0.47%)
Official Closing Price Updated: 7:00 PM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,624,738
Open 31.53
Bid (Size) 32.00 (1,700)
Ask (Size) 32.19 (1,000)
Prev. Close 31.74
Today's Range 31.47 - 31.89
52wk Range 12.46 - 31.99
Shares Outstanding 1,110,352,397
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why a $34 Million Teva Stock Position Signals Confidence in a Long Repair Story ↗
December 27, 2025
Why a $34 Million Teva Stock Position Signals Confidence in a Long Repair Story 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
December 24, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire

Performance

YTD
+49.7%
+49.7%
1 Month
+18.6%
+18.6%
3 Month
+66.3%
+66.3%
6 Month
+90.3%
+90.3%
1 Year
+42.9%
+42.9%

More News

Read More
News headline image
Billionaire Stanley Druckenmiller Sold Nvidia and Palantir and Piled Into One of Wall Street's Hottest Drug Stocks Ahead of 2026 ↗
December 24, 2025
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
December 19, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
News headline image
My Top 10 Portfolio Holdings for 2026 ↗
December 19, 2025
Via The Motley Fool
Topics Stocks
News headline image
3 Things You Need to Know if You Buy Teva Pharmaceutical Stock Today ↗
December 17, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead? ↗
December 14, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
December 12, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
News headline image
Teva Releases Q4 2025 Aide Memoire
December 12, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
News headline image
Glenview Capital Management Sells $71 Million of Alight Stake After Stock's 71% Drop ↗
December 09, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Glenview Doubles Down on Teva Stock With $72 Million Buy, According to Recent SEC Filing ↗
December 09, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
December 09, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
News headline image
Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035
December 03, 2025
Via MarketMinute
Topics Artificial Intelligence Death Intellectual Property
News headline image
30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks ↗
November 30, 2025
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared ↗
November 27, 2025
Via Stocktwits
Topics ETFs
News headline image
JPMorgan Says 2027 Medicare Drug Prices Signal Up To 40% Cuts Ahead — Novo Nordisk And Teva Stand Out As Top Targets ↗
November 26, 2025
Via Stocktwits
Topics Economy Government
News headline image
Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied ↗
November 26, 2025
Via Investor's Business Daily
Topics Economy Government
News headline image
Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®
November 25, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
News headline image
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December
November 21, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
News headline image
Jury Convicts Done Global Founder In Adderall Distribution Scheme: WSJ Report ↗
November 19, 2025
Via Benzinga
Topics Law Enforcement
News headline image
Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma’s Biggest Challenges
November 19, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
News headline image
Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves ↗
November 14, 2025
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
November 11, 2025
Via Benzinga
News headline image
Billionaire Stanley Druckenmiller Sold His Fund's Entire Stakes in Nvidia and Palantir for a Scorching-Hot Drug Stock That's Up 218% Since Mid-2023 ↗
November 11, 2025
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Here's How Much $100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today ↗
November 10, 2025
Via Benzinga

Frequently Asked Questions

Is Teva Pharmaceutical Industries Limited American Depositary Shares publicly traded?
Yes, Teva Pharmaceutical Industries Limited American Depositary Shares is publicly traded.
What exchange does Teva Pharmaceutical Industries Limited American Depositary Shares trade on?
Teva Pharmaceutical Industries Limited American Depositary Shares trades on the New York Stock Exchange
What is the ticker symbol for Teva Pharmaceutical Industries Limited American Depositary Shares?
The ticker symbol for Teva Pharmaceutical Industries Limited American Depositary Shares is TEVA on the New York Stock Exchange
What is the current price of Teva Pharmaceutical Industries Limited American Depositary Shares?
The current price of Teva Pharmaceutical Industries Limited American Depositary Shares is 31.89
When was Teva Pharmaceutical Industries Limited American Depositary Shares last traded?
The last trade of Teva Pharmaceutical Industries Limited American Depositary Shares was at 12/26/25 07:00 PM ET
What is the market capitalization of Teva Pharmaceutical Industries Limited American Depositary Shares?
The market capitalization of Teva Pharmaceutical Industries Limited American Depositary Shares is 35.41B
How many shares of Teva Pharmaceutical Industries Limited American Depositary Shares are outstanding?
Teva Pharmaceutical Industries Limited American Depositary Shares has 35B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap